Showing results (61-70 of 381) with videos related to
Sort By:
Pageof 39
Gene Therapy|March 29, 2018
Targeted in vivo knock-in of human alpha-1-antitrypsin cDNA using adenoviral delivery of CRISPR/Cas9Calvin J Stephens, Elena Kashentseva, William Everett, et al.Journal of Cellular Biochemistry|May 10, 2005
MDA-7/IL-24 regulates proliferation, invasion and tumor cell radiosensitivity: a new cancer therapy?Paul Dent, Adly Yacoub, Steven Grant, et al.Plos One|January 5, 2010
Derivation of a triple mosaic adenovirus for cancer gene therapyYizhe Tang, Hongju Wu, Hideyo Ugai, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|June 6, 2006
Adenovirus-mediated p53 tumor suppressor gene therapy of osteosarcomaVladimir V Ternovoi, David T Curiel, Bruce F Smith, et al.Methods in Molecular Biology (Clifton, N.J.)|February 19, 2004
Adenovirus-mediated gene delivery to dendritic cellsLaura Timares, Joanne T Douglas, Bryan W Tillman, et al.Virology|July 6, 2005
Genetic incorporation of HSV-1 thymidine kinase into the adenovirus protein IX for functional display on the virionJing Li, Long Le, Don A Sibley, et al.Journal of Virology|November 20, 2002
Construction and characterization of adenovirus serotype 5 packaged by serotype 3 hexonHongju Wu, Igor Dmitriev, Elena Kashentseva, et al.Molecular Cancer Therapeutics|March 21, 2006
Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenovirusesSvetlana Komarova, Yosuke Kawakami, Mariam A Stoff-Khalili, et al.Journal of Molecular Biology|January 9, 2007
Thermostability/infectivity defect caused by deletion of the core protein V gene in human adenovirus type 5 is rescued by thermo-selectable mutations in the core protein X precursorHideyo Ugai, Anton V Borovjagin, Long P Le, et al.Molecular Therapy Oncolytics|April 28, 2016
Retargeted oncolytic adenovirus displaying a single variable domain of camelid heavy-chain-only antibody in a fiber proteinElisabeth A van Erp, Lyudmila N Kaliberova, Sergey A Kaliberov, et al.Pageof 39